SEJLA GROSONJA: Open Payments
NPI 1124689948 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 55 payments from 18 companies in 2025. Trend: 2023 $572 · 2024 $442 · 2025 $1,503
Food & beverage: $1,456Education: $47
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $390 |
| GlaxoSmithKline, LLC. | 9 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $130 |
| HARMONY BIOSCIENCES LLC | 4 | $128 |
| Agios Pharmaceuticals, Inc. | 1 | $125 |
| Grifols USA, LLC | 4 | $100 |
| Verona Pharma, Inc. | 4 | $93 |
| GENZYME CORPORATION | 3 | $76 |
| MERZ NORTH AMERICA, INC. | 1 | $49 |
| Dexcom, Inc. | 2 | $47 |
Products named: AIRSUPRA, NUCALA, XIFAXAN, PYRUKYND, DUPIXENT, Prolastin-C Liquid, FASENRA, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
